Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Squillacote, M.D.
Eisai Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
137 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Queen Elizabeth Hospital
Woodville, South Australia, Australia
- Facility name not stated
Woodville South, South Australia, Australia
- Facility name not stated
Clayton, Victoria, Australia
- Facility name not stated
Fitzroy, Victoria, Australia
- Facility name not stated
Heidelberg, Victoria, Australia
- Facility name not stated
Parkville, Victoria, Australia
- Facility name not stated
Clayton, Australia
- Facility name not stated
Fitzroy, Australia
- Facility name not stated
Parkville, Australia
- Facility name not stated
West Heidelberg, Australia
- Facility name not stated
Woodville, Australia
- Facility name not stated
Pleven, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Brno, Czechia
- Facility name not stated
Olomouc, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Tartu, Estonia
- Facility name not stated
Düsseldorf, Germany
- Facility name not stated
Kehl-Kork, Germany
- Facility name not stated
Konigstein-Falkenstein, Germany
- Facility name not stated
Mainz, Germany
- Facility name not stated
Marburg, Germany
- Facility name not stated
München, Germany
- Facility name not stated
München, Germany
- Facility name not stated
Ulm, Germany
- Facility name not stated
Westerstede, Germany
- Queen Mary Hospital
Hong Kong, Hong Kong
- Facility name not stated
Hong Kong, Hong Kong
- Queen Elizabeth Hospital
Kowloon, Hong Kong
- United Christian Hospital
Kowloon, Hong Kong
- Facility name not stated
Kowloon, Hong Kong
- Prince of Wales Hospital
Shatin, Hong Kong
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 Aug 2009
- Completion
- 31 Jan 2010
- Last update posted
- 21 Jan 2016
- Registered enrollment
- 712
- Registry id
- NCT00700310
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.